Arkolith/Insider Trading/NVUS/Form 4

Lampert Mark N

InsiderEledon Pharmaceuticals, Inc. (NVUS) · full profile →Form 4 · filed Dec 28, 2020
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
12
6 non-derivative · 6 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 22, 2020Conversion(C)2K——16K
Dec 22, 2020Conversion(C)98K——113K
Dec 22, 2020Conversion(C)509K——599K
Dec 22, 2020Conversion(C)654K——772K
Dec 22, 2020Conversion(C)15K——118K
Dec 22, 2020Conversion(C)11K——89K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 22, 2020Conversion(C)203——0
Dec 22, 2020Conversion(C)35——0
Dec 22, 2020Conversion(C)9K——40K
Dec 22, 2020Conversion(C)2K——7K
Dec 22, 2020Conversion(C)273——0
Dec 22, 2020Conversion(C)12K——52K

Transaction Codes

C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000921895-20-003278) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Eledon Pharmaceuticals, Inc.

Build

Ask your agent about NVUS insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0000921895-20-003278"
Ask your agent
Use Arkolith to summarize insider buying and selling at Eledon Pharmaceuticals, Inc.
over the last 90 days and cite the filings.